Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06157671 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The LINFU® U.S. Registry for the Detection of Asymptomatic Pancreatic Ductal Adenocarcinoma

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. 4 versions Re-verified since Feb 18, 2024, no change to tracked fieldsv3-v6
  2. Trial status: Not Yet Recruiting to Enrolling by Invitationv2 Show 5 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 15, 2024 to Jan 31, 2024
    • Study description shortened, about 29 words
    • Study arms: 2 to 1
    • Eligibility criteria expanded, about 4 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adenocyte has developed LINFU®, (Low Intensity Non-Focused Ultrasound excitation of the pancreas) as a method of identifying early, asymptomatic pancreatic cancer and its noninvasive precancerous lesions. The test involves ultrasound and an analysis of pancreatic juice. A neural network-based computer-assisted system may be utilized to enhance the analysis. Patients enrolled are being screened for pancreatic cancer because they have known risk factors (i.e. smoking, diabetes, chronic pancreatitis, family history of pancreatic cancer, or certain genetic syndromes).
Trial Details
NCT Number NCT06157671
Lead Sponsor Adenocyte, LLC
Conditions
(from sponsor)		 Pancreatic Adenocarcinoma, Pancreatic Intraepithelial Neoplasia
Enrollment 1,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov